Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Complete Title: A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients with Cancer
Trial Phase: I/II
Investigator: John Liao
A Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.
Keywords:
- Brain Cancer
- Breast Cancer
- Cervical Cancer
- Esophageal Cancer
- Gastric Cancer
- Glioma
- Head and Neck Cancer
- Melanoma
- Mesothelioma
- Ovarian Cancer
- Solid Tumors
- Thyroid Cancer
- Lung Carcinoma, Non-Small-Cell (NSCLC)
- Colorectal Neoplasms
- Neoplasms, Advanced Malignant
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
Pediatric
I/II
John Liao
RG1122687
NCT05500508
A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients with Cancer
Brain Cancer
Breast Cancer
Cervical Cancer
Esophageal Cancer
Gastric Cancer
Glioma
Head and Neck Cancer
Melanoma
Mesothelioma
Ovarian Cancer
Solid Tumors
Thyroid Cancer
Lung Carcinoma, Non-Small-Cell (NSCLC)
Colorectal Neoplasms
Neoplasms, Advanced Malignant